QBIO

Q BioMed Inc. QBIO

QBIO
Q BioMed Inc. RGIN
Regenicin, Inc. VOQP
VioQuest Pharmaceuticals, Inc. OZYMF
Strategic Partners A/S XSNX
NovAccess Global Inc. NNLX
NanoLogix, Inc. PXMD
PaxMedica, Inc. Common Stock VAXX
Vaxxinity, Inc. SCPS
Scopus BioPharma Inc. RCAR
RenovaCare, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode QBIO RGIN VOQP OZYMF XSNX NNLX PXMD VAXX SCPS RCAR
6M 9 900.00 % 400.00 % 0.00 % 0.00 % -66.67 % 0.00 % 0.00 % -75.00 % 33.33 % 0.00 %
YTD 9 900.00 % 400.00 % 0.00 % 0.00 % -92.31 % 0.00 % -99.85 % 150.00 % 33.33 % 0.00 %
1Y 9 900.00 % 49 900.00 % 0.00 % 0.00 % -98.08 % 0.00 % -99.85 % 3 025.00 % 33.33 % 0.00 %
3Y -99.23 % 400.00 % 0.00 % -40.00 % -99.96 % 0.00 % -100.00 % -99.19 % -99.68 % -99.60 %
5Y -99.99 % -96.50 % -72.73 % -99.27 % -99.98 % -99.86 % -100.00 % -99.92 % -100.00 % -100.00 %
10Y -100.00 % -97.62 % -70.00 % -98.95 % -100.00 % -99.83 % -100.00 % -99.92 % -99.99 % -99.99 %
From the beginning -99.98 % -99.95 % -100.00 % -98.95 % -100.00 % -99.97 % -100.00 % -99.92 % -99.99 % -99.99 %

Dividend